| | The business, property and affairs of Par Pharmaceutical Companies, Inc.™ (Par) are managed under the direction of the Company's Board of Directors. Members of the Board are kept informed through appropriate correspondence and discussions with the Company's executive chairman, chief executive officer, and other officers, by reviewing materials provided to them, by visiting our offices and plants, and by participating in meetings of the Board and its committees.
It is Par's policy to conform to all appropriate policies and procedures regarding the management of publicly traded companies as indicated in the Corporate Governance Guidelines. Par also requires its officers, employees, and directors to comply with the Company's Code of Ethics.
In addition, Par is committed to maintaining an effective compliance program in accordance with guidance issued by the Office of Inspector General (the "OIG Guidance") and voluntary guidelines issued by the Pharmaceutical Research and Manufacturers of America (the "PhRMA Code").
|
 |
Selected committees of the board are responsible for specific Company policies and procedures:Other corporate governance documents available for review on this web site include: |
|
